Table 5.

Characteristics Between LAM-Negative and LAM-Positive HIV-Associated Tuberculosis (N = 194)

CharacteristicsLAM-Negative TB
(N = 138)
LAM-Positive TB
(N = 56)
P Value
Mean ± SD or N (%)Mean ± SD or N (%)
Demographic and Education
 Age (years)35.3 ± 10.434.0 ± 7.5.30
 Male sex83 (60.1)34 (60.7)1.0
 Completed high school50 (36.5)15 (26.8).24
Clinical
 Prior TB infection9 (6.5)5 (8.9).55
 Currently smoke tobacco32 (23.2)8 (14.3).24
 Body temperature36.5 ± 1.236.5 ± 1.5.77
 Fever (temperature >38.3°C)8 (9.4)5 (10.2)1.0
 Heart rate97.7 ± 22.9115.2 ± 26.0.0002
 Tachycardia (>100 heart beats/minute)39 (44.8)32 (65.3).03
 Systolic blood pressure113.5 ± 16.0104.7 ± 21.0.01
 Diastolic blood pressure73.2 ± 16.368.3 ± 12.3.06
TB-Related Symptoms
 Current cough60 (43.5)32 (57.1).11
 Fever58 (42.0)23 (41.1)1.0
 Night sweats59 (42.8)28 (50.0).43
 Weight loss75 (54.4)30 (53.6)1.0
 Having any of 4 TB-related symptoms104 (75.4)46 (82.1).35
 Having ≥2 TB-related symptoms72 (52.2)36 (64.3).15
CD4 Cell Count
 Median [IQR] CD4 cells/mm3115 [48–227]61 [20–146].002
 Low CD4 (<100 cells/mm3)58 (45.3)36 (66.7).01
Sputum AFB Microscopy Results
 AFB negative106 (80.9)41 (77.4).37
 AFB positive with “scant” or 1+20 (15.3)6 (11.3)
 AFB positive with ≥2+5 (3.8)6 (11.3)
Sputum TB Culture Results
 Liquid culture (MGIT) positive78 (60.9)38 (74.5).09
 Solid culture positive42 (32.1)33 (64.7).0002
 Either culture positive82 (62.6)41 (80.4).02
Treatment Outcomes
 Failed, defaulted, or not completed treatment39 (47.6)21 (56.8).35
 Death during 12-month follow-up period19 (13.8)19 (33.9).001
CharacteristicsLAM-Negative TB
(N = 138)
LAM-Positive TB
(N = 56)
P Value
Mean ± SD or N (%)Mean ± SD or N (%)
Demographic and Education
 Age (years)35.3 ± 10.434.0 ± 7.5.30
 Male sex83 (60.1)34 (60.7)1.0
 Completed high school50 (36.5)15 (26.8).24
Clinical
 Prior TB infection9 (6.5)5 (8.9).55
 Currently smoke tobacco32 (23.2)8 (14.3).24
 Body temperature36.5 ± 1.236.5 ± 1.5.77
 Fever (temperature >38.3°C)8 (9.4)5 (10.2)1.0
 Heart rate97.7 ± 22.9115.2 ± 26.0.0002
 Tachycardia (>100 heart beats/minute)39 (44.8)32 (65.3).03
 Systolic blood pressure113.5 ± 16.0104.7 ± 21.0.01
 Diastolic blood pressure73.2 ± 16.368.3 ± 12.3.06
TB-Related Symptoms
 Current cough60 (43.5)32 (57.1).11
 Fever58 (42.0)23 (41.1)1.0
 Night sweats59 (42.8)28 (50.0).43
 Weight loss75 (54.4)30 (53.6)1.0
 Having any of 4 TB-related symptoms104 (75.4)46 (82.1).35
 Having ≥2 TB-related symptoms72 (52.2)36 (64.3).15
CD4 Cell Count
 Median [IQR] CD4 cells/mm3115 [48–227]61 [20–146].002
 Low CD4 (<100 cells/mm3)58 (45.3)36 (66.7).01
Sputum AFB Microscopy Results
 AFB negative106 (80.9)41 (77.4).37
 AFB positive with “scant” or 1+20 (15.3)6 (11.3)
 AFB positive with ≥2+5 (3.8)6 (11.3)
Sputum TB Culture Results
 Liquid culture (MGIT) positive78 (60.9)38 (74.5).09
 Solid culture positive42 (32.1)33 (64.7).0002
 Either culture positive82 (62.6)41 (80.4).02
Treatment Outcomes
 Failed, defaulted, or not completed treatment39 (47.6)21 (56.8).35
 Death during 12-month follow-up period19 (13.8)19 (33.9).001

Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; LAM, lipoarabinomannan; SD, standard deviation; TB, tuberculosis.

Table 5.

Characteristics Between LAM-Negative and LAM-Positive HIV-Associated Tuberculosis (N = 194)

CharacteristicsLAM-Negative TB
(N = 138)
LAM-Positive TB
(N = 56)
P Value
Mean ± SD or N (%)Mean ± SD or N (%)
Demographic and Education
 Age (years)35.3 ± 10.434.0 ± 7.5.30
 Male sex83 (60.1)34 (60.7)1.0
 Completed high school50 (36.5)15 (26.8).24
Clinical
 Prior TB infection9 (6.5)5 (8.9).55
 Currently smoke tobacco32 (23.2)8 (14.3).24
 Body temperature36.5 ± 1.236.5 ± 1.5.77
 Fever (temperature >38.3°C)8 (9.4)5 (10.2)1.0
 Heart rate97.7 ± 22.9115.2 ± 26.0.0002
 Tachycardia (>100 heart beats/minute)39 (44.8)32 (65.3).03
 Systolic blood pressure113.5 ± 16.0104.7 ± 21.0.01
 Diastolic blood pressure73.2 ± 16.368.3 ± 12.3.06
TB-Related Symptoms
 Current cough60 (43.5)32 (57.1).11
 Fever58 (42.0)23 (41.1)1.0
 Night sweats59 (42.8)28 (50.0).43
 Weight loss75 (54.4)30 (53.6)1.0
 Having any of 4 TB-related symptoms104 (75.4)46 (82.1).35
 Having ≥2 TB-related symptoms72 (52.2)36 (64.3).15
CD4 Cell Count
 Median [IQR] CD4 cells/mm3115 [48–227]61 [20–146].002
 Low CD4 (<100 cells/mm3)58 (45.3)36 (66.7).01
Sputum AFB Microscopy Results
 AFB negative106 (80.9)41 (77.4).37
 AFB positive with “scant” or 1+20 (15.3)6 (11.3)
 AFB positive with ≥2+5 (3.8)6 (11.3)
Sputum TB Culture Results
 Liquid culture (MGIT) positive78 (60.9)38 (74.5).09
 Solid culture positive42 (32.1)33 (64.7).0002
 Either culture positive82 (62.6)41 (80.4).02
Treatment Outcomes
 Failed, defaulted, or not completed treatment39 (47.6)21 (56.8).35
 Death during 12-month follow-up period19 (13.8)19 (33.9).001
CharacteristicsLAM-Negative TB
(N = 138)
LAM-Positive TB
(N = 56)
P Value
Mean ± SD or N (%)Mean ± SD or N (%)
Demographic and Education
 Age (years)35.3 ± 10.434.0 ± 7.5.30
 Male sex83 (60.1)34 (60.7)1.0
 Completed high school50 (36.5)15 (26.8).24
Clinical
 Prior TB infection9 (6.5)5 (8.9).55
 Currently smoke tobacco32 (23.2)8 (14.3).24
 Body temperature36.5 ± 1.236.5 ± 1.5.77
 Fever (temperature >38.3°C)8 (9.4)5 (10.2)1.0
 Heart rate97.7 ± 22.9115.2 ± 26.0.0002
 Tachycardia (>100 heart beats/minute)39 (44.8)32 (65.3).03
 Systolic blood pressure113.5 ± 16.0104.7 ± 21.0.01
 Diastolic blood pressure73.2 ± 16.368.3 ± 12.3.06
TB-Related Symptoms
 Current cough60 (43.5)32 (57.1).11
 Fever58 (42.0)23 (41.1)1.0
 Night sweats59 (42.8)28 (50.0).43
 Weight loss75 (54.4)30 (53.6)1.0
 Having any of 4 TB-related symptoms104 (75.4)46 (82.1).35
 Having ≥2 TB-related symptoms72 (52.2)36 (64.3).15
CD4 Cell Count
 Median [IQR] CD4 cells/mm3115 [48–227]61 [20–146].002
 Low CD4 (<100 cells/mm3)58 (45.3)36 (66.7).01
Sputum AFB Microscopy Results
 AFB negative106 (80.9)41 (77.4).37
 AFB positive with “scant” or 1+20 (15.3)6 (11.3)
 AFB positive with ≥2+5 (3.8)6 (11.3)
Sputum TB Culture Results
 Liquid culture (MGIT) positive78 (60.9)38 (74.5).09
 Solid culture positive42 (32.1)33 (64.7).0002
 Either culture positive82 (62.6)41 (80.4).02
Treatment Outcomes
 Failed, defaulted, or not completed treatment39 (47.6)21 (56.8).35
 Death during 12-month follow-up period19 (13.8)19 (33.9).001

Abbreviations: HIV, human immunodeficiency virus; IQR, interquartile range; LAM, lipoarabinomannan; SD, standard deviation; TB, tuberculosis.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close